These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10626910)

  • 21. Coengagement of CD2 with LFA-1 or VLA-4 by bispecific ligand fusion proteins primes T cells to respond more effectively to T cell receptor-dependent signals.
    Dietsch MT; Chan PY; Kanner SB; Gilliland LK; Ledbetter JA; Linsley PS; Aruffo A
    J Leukoc Biol; 1994 Oct; 56(4):444-52. PubMed ID: 7523557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection.
    Rölle A; Halenius A; Ewen EM; Cerwenka A; Hengel H; Momburg F
    Eur J Immunol; 2016 Oct; 46(10):2420-2425. PubMed ID: 27469079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of an immunomodulatory LFA3-IgG1 fusion protein on nonhuman primates.
    Chisholm PL; Williams CA; Jones WE; Majeau GR; Oleson FB; Burrus-Fischer B; Meier W; Hochman PS
    Ther Immunol; 1994 Aug; 1(4):205-16. PubMed ID: 7584496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human naive and memory T-helper cells display distinct adhesion properties to ICAM-1, LFA-3 and B7 molecules.
    Parra E; Wingren AG; Hedlund G; Sjögren HO; Kalland T; Sansom D; Dohlsten M
    Scand J Immunol; 1993 Dec; 38(6):508-14. PubMed ID: 7504826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multimeric form of soluble recombinant sheep LFA-3 (CD58) inhibits human T-cell proliferation.
    Yamashita K; Parish CR; Warren HS; Harrison LC
    Immunology; 1997 Sep; 92(1):39-44. PubMed ID: 9370922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles.
    Wingren AG; Parra E; Varga M; Kalland T; Sjögren HO; Hedlund G; Dohlsten M
    Crit Rev Immunol; 1995; 15(3-4):235-53. PubMed ID: 8834450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A model for CD2/CD58-mediated adhesion strengthening.
    Shao JY; Yu Y; Dustin ML
    Ann Biomed Eng; 2005 Apr; 33(4):483-93. PubMed ID: 15909654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short course single agent therapy with an LFA-3-IgG1 fusion protein prolongs primate cardiac allograft survival.
    Kaplon RJ; Hochman PS; Michler RE; Kwiatkowski PA; Edwards NM; Berger CL; Xu H; Meier W; Wallner BP; Chisholm P; Marboe CC
    Transplantation; 1996 Feb; 61(3):356-63. PubMed ID: 8610340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppression by co-stimulatory molecules: inhibition of CD2-CD48/CD58 interaction by peptides from CD2 to suppress progression of collagen-induced arthritis in mice.
    Gokhale A; Kanthala S; Latendresse J; Taneja V; Satyanarayanajois S
    Chem Biol Drug Des; 2013 Jul; 82(1):106-18. PubMed ID: 23530775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein-Protein Interaction.
    Sable R; Durek T; Taneja V; Craik DJ; Pallerla S; Gauthier T; Jois S
    ACS Chem Biol; 2016 Aug; 11(8):2366-74. PubMed ID: 27337048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
    Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
    Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion.
    Dustin ML; Springer TA
    Annu Rev Immunol; 1991; 9():27-66. PubMed ID: 1716919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The structural biology of CD2.
    Moingeon P; Chang HC; Sayre PH; Clayton LK; Alcover A; Gardner P; Reinherz EL
    Immunol Rev; 1989 Oct; 111():111-44. PubMed ID: 2576417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial cell costimulation of T cell activation through CD58-CD2 interactions involves lipid raft aggregation.
    Mestas J; Hughes CC
    J Immunol; 2001 Oct; 167(8):4378-85. PubMed ID: 11591762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation.
    Van Seventer GA; Shimizu Y; Horgan KJ; Luce GE; Webb D; Shaw S
    Eur J Immunol; 1991 Jul; 21(7):1711-8. PubMed ID: 1711977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional CD2 mutants unable to bind to, or be stimulated by, LFA-3.
    Wolff HL; Burakoff SJ; Bierer BE
    J Immunol; 1990 Feb; 144(4):1215-20. PubMed ID: 1689346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligand intercellular adhesion molecule 1 has a necessary role in activation of integrin lymphocyte function-associated molecule 1.
    Cabañas C; Hogg N
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5838-42. PubMed ID: 7685913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen.
    Koyasu S; Lawton T; Novick D; Recny MA; Siliciano RF; Wallner BP; Reinherz EL
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2603-7. PubMed ID: 1690889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of receptor lateral mobility on adhesion strengthening between membranes containing LFA-3 and CD2.
    Chan PY; Lawrence MB; Dustin ML; Ferguson LM; Golan DE; Springer TA
    J Cell Biol; 1991 Oct; 115(1):245-55. PubMed ID: 1717480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse LFA-3 studied with chimeric soluble CD2 shows preferential expression on lymphoid cells.
    Rutschmann R; Karjalainen K
    Eur J Immunol; 1991 Jun; 21(6):1379-84. PubMed ID: 1710564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.